logo

IRWD

Ironwood Pharmaceuticals
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

IRWD fundamentals

Ironwood Pharmaceuticals (IRWD) released its earnings on May 7, 2025: revenue was 41.14M (YoY -45.05%), missed estimates; EPS was -0.14 (YoY -600.00%), missed estimates.
Revenue / YoY
41.14M
-45.05%
EPS / YoY
-0.14
-600.00%
Report date
May 7, 2025
Earnings Call
8:30 AM on May 8, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

IRWD has released its 2025 Q1 earnings report, with revenue of 41.14M, reflecting a YoY change of -45.05%, and net profit of -37.39M, showing a YoY change of -798.27%. The Sankey diagram below clearly presents IRWD's revenue sources and cost distribution.

Key Indicators

Ironwood Pharmaceuticals (IRWD) key financial stats and ratios, covering profitability, financial health, and leverage.
Ironwood Pharmaceuticals (IRWD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ironwood Pharmaceuticals (IRWD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ironwood Pharmaceuticals (IRWD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ironwood Pharmaceuticals (IRWD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ironwood Pharmaceuticals (IRWD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield